skip to Main Content
  • This page as PDF
September 22, 2020 12:00 - 1:00 PM ET

Market Access Enablement Strategies, Part 2: Navigating Policy and Marketplace Developments


Join Avalere experts for Part 2 of our Market Access Enablement Strategies webinar series, to learn about the policy changes and market factors that could impact the future relationships between manufacturers, health plans and pharmacy benefit managers.

Recent pricing and policy developments may create major shifts in plan design and preparation. Join our policy and market access experts to evaluate forward-leaning considerations and perspectives for how to best prepare for and adapt your business strategies.

Key Topics:

  • Executive orders related to drug pricing (e.g., rebate rule, importation, international pricing index, 340B)
  • State-level regulation and legislation
  • CMS’s proposed value-based purchasing rule: possible impact on manufacturers, healthcare plans, and PBMs
  • COVID-19 impacts and coverage shifts


Sarah Butler , Head, Client Solutions, Marketing & Operations

Sarah Butler is the head of Sales, Marketing, and Operations.

Lance Grady , Practice Director, Commercialization & Regulatory Strategy

Lance Grady leads the Market Access Practice.

John C. Neal , Managing Director, Commercialization & Regulatory Strategy

John C. Neal partners with pharmaceutical and biotech clients to develop market access assessments and launch strategies designed to ensure successful commercialization of assets.

Megan Olsen , Associate Principal, Policy

Megan Olsen supports clients in anticipating and navigating the evolving federal and state health policy environment.

From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top